SCHEMBL6326690

SCHEMBL6326690

Nc1ccc(C(=O)c2cccs2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 1.00
HTT P42858 1/20 1.00
HPGDS O60760 1/20 0.69
MAPT P10636 6/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
LMNA P02545 3/20 0.57
GFER P55789 1/20 0.57
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
ALDH1A1 P00352 4/20 0.57
CYP2C9 P11712 2/20 0.57
PTGS1 P23219 2/20 0.57
PTGS2 P35354 2/20 0.57
KDM4E B2RXH2 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
TSHR P16473 1/20 0.57
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6793430 0.90 HPGDS (0.83) HPGDHTTHPGDSMAPTMEN1
SCHEMBL7485708 0.82 HPGDS (0.71) HPGDHTTHPGDSMAPTMEN1
SCHEMBL8439895 0.82 HPGDS (0.78) HPGDHTTHPGDSMAPTMEN1
SCHEMBL158020 0.82 HPGDS (1.00) HPGDHTTHPGDSMAPTMEN1
SCHEMBL5591866 0.81 HPGDS (0.69) HPGDHTTHPGDSMAPTMEN1
SCHEMBL4420563 0.81 HPGDS (0.69) HPGDHTTHPGDSMAPTMEN1
SCHEMBL2760408 0.81 HPGDS (0.69) HPGDHTTHPGDSMAPTMEN1
SCHEMBL11306574 0.81 HPGDS (0.69) HPGDHTTHPGDSMAPTMEN1
SCHEMBL2074541 0.81 HPGDS (0.69) HPGDHTTHPGDSMAPTMEN1
SCHEMBL7075260 0.81 HPGDS (0.69) HPGDHTTHPGDSMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 BRISTOL-MYERS SQUIBB CO. 2005-06-09 US disclosed
US-4980349-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, ANTICOAGULANTS SANOFI (FR) 1990-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 SERPINE1, SERPINC1, SERPINB1 HPGD 149/4885HTT 2797/4885HPGDS 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.